Treatment and prevention of chronic viral hepatitis
Lumio, J.; Vuoristo, M.
Duodecim; Laaketieteellinen Aikakauskirja 110(20): 1883-1892
1994
ISSN/ISBN: 0012-7183 PMID: 7555802 Document Number: 432860
Document emailed within 1 workday
Related Documents
Pár, A. 1992: Pathogenesis, therapy, prevention and prognosis in chronic viral hepatitis Orvosi Hetilap 133 Suppl. 1: 51-63Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Xu, J.-h.; Yu, Y.-y.; Si, C.-w.; Chen, X.-y.; Han, Z.-h.; Chen, Y.; Li, X.-y. 2009: A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment Zhonghua Yi Xue Za Zhi 89(41): 2902-2905
Hobstová, J.; Vitous, A. 2011: Viral hepatitis at the beginning of the 21st century--value of liver biopsy in the context of development of new non-invasive diagnostic methods and in relation to the modern therapy of chronic viral hepatitis Ceskoslovenska Patologie 47(2): 44-49
Bane, A. 2008: Viral hepatitis: epidemiology, treatment, prevention Ethiopian Medical Journal 46(2): 193-200
Tsega, E. 2000: Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments Ethiopian Medical Journal 38(2): 131-141
Wright, H.I. 1990: Interferon treatment of chronic viral hepatitis G.E.N 44(1): 71-77
Pirovino, M. 1992: Interferon treatment of chronic viral hepatitis Therapeutische Umschau. Revue Therapeutique 49(5): 302-309
Ouzan, D. 1994: Epidemiologic studies and treatment of chronic viral hepatitis C Medecine Tropicale: Revue du Corps de Sante Colonial 54(3 Suppl): 18-20
Neronov, V.A. 2009: Experience with the use of ozone for the treatment of chronic viral hepatitis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 14-17
Beker, S.; Pujol, F.H.; Beker, B. 1995: Is the treatment of chronic viral hepatitis C with interferon-alpha effective? G.E.N 49(2): 165-169
Tănăsescu, C.; Ionescu, R. 2010: Treatment of extrahepatic manifestations of chronic hepatitis C viral infection--a challenge Romanian Journal of Internal Medicine 48(1): 3-7
Ettinger, O.A.; Nikitin, I.G.; Storozhakov, G.I. 1999: Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis Terapevticheskii Arkhiv 71(12): 69-72
Tremolada, F.; Fattovich, G.; Panebianco, G.; Ongaro, G.; Realdi, G. 1980: Suppressor cell activity in viral and non-viral chronic active hepatitis Clinical and Experimental Immunology 40(1): 89-95
Xin-Hua, W.; Chang-Qing, L.; Xing-Bo, G.; Lin-Chun, F. 2001: A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B Southeast Asian Journal of Tropical Medicine and Public Health 32(1): 140-142
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Csatary, L.K.; Schnabel, R.; Bakács, T. 1999: Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine Anticancer Research 19(1b): 629-633
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Nishikawa, H. 2015: Treatment efficacy and safety in elderly genotype 1b chronic hepatitis C patients with high viral load Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 209-213
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489